New Study Concludes Xlear Kills and/or Deactivates SARS-CoV-2; Efficacy Against New Variants
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
The collaborative study concludes: "Because there are no risk factors in using the X/GSE combination therapy, and [Xlear] nasal spray is over the counter available without prescription, and [Xlear] allows for comfortable long term mask wearing, adoption of this preventive anti-viral therapy should be encouraged."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
EVANSTON, Illinois -- Businesswire -- A new in vitro study done collaboratively by Utah State University and Northwestern University finds Xlear components (grapefruit seed extract and xylitol) significantly eliminates SARS-CoV-2, the virus that causes COVID-19. The imaging research study component was performed at the BioCryo facility of Northwestern University’s NUANCE Center.
The study tested SARS-CoV-2 virus titers and LRV against a single concentration of Xlear nasal spray. According to the Study, “After a 25-minute contact time, the nasal spray reduced virus from 4.2 to 1.7 log10 CCID50 per 0.1 mL, a statistically significant reduction (P<0.001) of 2.5 log10 CCID50.” The Northwestern/Utah State Study is the newest in a string of studies to reach the conclusion that Xlear is effective against the SARS-CoV-2.
However, the study breaks new ground in two vital respects: “First, we conclude, in addition to countering SARS-CoV-2, Xlear is likely effective in preventing the spread of future H1N1 viruses, including the emerging SARS-CoV-2 variants, along with other viral epidemics. Given the more transmissible variants we now face, this is critical now,” said Professor Mark Cannon, Feinberg School of Medicine, Northwestern University. “Second, using electron microscopy, we have visual evidence showing that xylitol and GSE counters the virus. The GSE kills the virus, while the xylitol prevents the virus from attaching to the cell walls. The image (attached) shows SARS-CoV-2 viruses outside the cell and never attached, thereby preventing infection,” added Dr. Cannon. The study postulates that xylitol acts as a decoy target for SARS-CoV-2, preventing virus attachment to the core protein on the cell wall.
The collaborative study concludes: “Because there are no risk factors in using the X/GSE combination therapy, and [Xlear] nasal spray is over the counter available without prescription, and [Xlear] allows for comfortable long term mask wearing, adoption of this preventive anti-viral therapy should be encouraged.”
Full study: https://www.biorxiv.org/content/10.1101/2020.12.02.408575v3.full
For more information on Xlear (including where to obtain): https://xlear.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210126005436/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Xlear, Inc.
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 제주삼다수 광고영상 조회수 1000만 뷰 돌파… 광고 비하인드 필름 추가 공개 - 뉴스와이어
- 빛의 시어터, 5월 24일 개막 전시 ‘베르메르부터 반 고흐까지, 네덜란드 거장들’ 얼리버드 티켓
- hy, 특허 소재 ‘아이스플랜트복합농축액’ 숙취해소 기능성 입증 - 뉴스와이어
- 남유준 입셀 CTO, 식약처 주관 규제과학 혁신포럼서 유도만능줄기세포의 치료전략에 대해 발표 -
- LG CNS, 연세대학교와 ‘DX 인재’ 육성 맞손 - 뉴스와이어
- KB금융그룹, 금융권 최초 계열사간 고객센터 연계 상담 서비스 오픈 - 뉴스와이어
- 대동CMC, 산업맞춤형 혁신바우처 공급기업 선정 - 뉴스와이어
- 국립심포니오케스트라, 2024 KNSO국제아카데미 본격 출항 - 뉴스와이어
- 정관장, 미국에서 국제세미나 통해 대한민국 홍삼 우수성 알려 - 뉴스와이어
- 클리오, 일본 핵심 벤더업체 인수 통해 글로벌 신성장동력 확보 - 뉴스와이어